Study types
- preprint 24
- article 19
- other 3
- supplementary-materials 2
Condition tags
- endometriosis 47
- mesh:D004715 6
Top journals
Frequent coauthors
- Anda M Vlad 39
- Raluca A. Budiu 34
- Xin Huang 32
- Swati Suryawanshi 32
- Esther Elishaev 32
- Suketu Mansuria 29
- Ted Lee 28
- Gina Mantia-Smaldone 27
- Nicole Donnellan 27
- George C. Tseng 24
preprint
2023
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
preprint
2023
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
preprint
2023
AbstractBackground: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian canc…
preprint
2023
AbstractBackground: Comorbidities can affect survival of ovarian cancer patients by influencing treatment efficacy. However, little evidence exists on the association between individual concurrent comorbidities and prognosis in ovarian canc…
preprint
2023
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
preprint
2023
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
preprint
2023
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
preprint
2023
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
preprint
2023
Supplementary Materials and Methods
preprint
2023
Supplementary Materials and Methods
supplementary-materials
2023
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
supplementary-materials
2023
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
preprint
2023
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
preprint
2023
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
preprint
2023
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
preprint
2023
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
preprint
2023
Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity
preprint
2023
Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity
preprint
2023
Suppl Fig S4. Complement and non-target siRNA
preprint
2023
Suppl Fig S4. Complement and non-target siRNA
preprint
2023
Suppl Table S1. Differentially expressed genes from different group comparisons
preprint
2023
Suppl Table S1. Differentially expressed genes from different group comparisons
preprint
2023
Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses
preprint
2023
Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses
preprint
2023
Suppl Table S3. Top five networks from different group comparisons, identified via Ingenuity Pathway Analyses